Ovid Therapeutics Inc (OVID)

Apr 23, 2026

OVID Ovid Therapeutics Inc. far exceeds Q4 2025 EPS expectations, shares rise nearly four percent.Profit Guidance - Cổng thông tin điện tử Tỉnh Sơn La

Apr 23, 2026

Apr 22, 2026

OVID (Ovid Therapeutics) delivers blowout Q4 2025 results, but stock dips slightly amid mild investor profit taking.Deceleration Risk - Xã Thanh Hà

Apr 22, 2026

Apr 21, 2026

29.86M-share resale registration by Ovid Therapeutics (NASDAQ: OVID) - Stock Titan

Apr 21, 2026

Apr 20, 2026

H.C. Wainwright reiterates Ovid Therapeutics stock rating at buy By Investing.com - Investing.com India

Apr 20, 2026

Apr 20, 2026

Ovid Therapeutics receives $53.9 million from warrant exercises By Investing.com - Investing.com India

Apr 20, 2026

Apr 20, 2026

Ovid Therapeutics Boosts Capital Through Warrant Exercises - TipRanks

Apr 20, 2026

Apr 20, 2026

Ovid Therapeutics receives $53.9 million from warrant exercises - Investing.com

Apr 20, 2026

Apr 20, 2026

Ovid Therapeutics sees $53.9M gross proceeds as Series A warrants mostly exercised - TradingView

Apr 20, 2026

Apr 20, 2026

Warrant exercises bring Ovid Therapeutics (NASDAQ: OVID) $53.9M cash - Stock Titan

Apr 20, 2026

Apr 20, 2026

H.C. Wainwright reiterates Ovid Therapeutics stock rating at buy - Investing.com

Apr 20, 2026

Apr 18, 2026

William Blair Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Announces Target Price $5.24 - 富途牛牛

Apr 18, 2026

Apr 17, 2026

LifeSci Capital Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $5 - Moomoo

Apr 17, 2026

Apr 16, 2026

William Blair Maintains Ovid Therapeutics(OVID.US) With Buy Rating - 富途牛牛

Apr 16, 2026

Apr 15, 2026

OVID.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 15, 2026

Apr 15, 2026

OVID Reiterated by Wedbush -- Price Target Maintained at $7.00 - GuruFocus

Apr 15, 2026

Apr 15, 2026

Leerink reiterates Ovid Therapeutics stock rating on KCC2 potential By Investing.com - Investing.com South Africa

Apr 15, 2026

Apr 15, 2026

Leerink reiterates Ovid Therapeutics stock rating on KCC2 potential - Investing.com

Apr 15, 2026

Apr 15, 2026

Ovid Therapeutics' (OVID) "Outperform" Rating Reiterated at Wedbush - MarketBeat

Apr 15, 2026

Apr 15, 2026

Ovid Therapeutics Inc. (OVID) Discusses KCC2 Deep Dive and Pipeline Advances in CNS DisordersSlideshow - Seeking Alpha

Apr 15, 2026

Apr 13, 2026

Value Recap: What hedge funds are buying Ovid Therapeutics Inc2026 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

VIX Spike: Does Ovid Therapeutics Inc have declining or rising EPS2026 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

HC Wainwright Issues Positive Forecast for OVID Earnings - MarketBeat

Apr 13, 2026

Apr 10, 2026

Whale Trades: What are Ovid Therapeutics Incs growth levers2026 Gainers & Low Volatility Stock Recommendations - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

OVID Should I Buy - Intellectia AI

Apr 10, 2026

Apr 10, 2026

H.C. Wainwright raises Ovid Therapeutics stock price target to $4 By Investing.com - Investing.com Australia

Apr 10, 2026

Apr 09, 2026

[Form 4] Ovid Therapeutics Inc. Insider Trading Activity - Stock Titan

Apr 09, 2026

Apr 09, 2026

Ovid Therapeutics (NASDAQ: OVID) director granted RSUs in lieu of cash pay - Stock Titan

Apr 09, 2026

Apr 09, 2026

Director Kevin Fitzgerald awarded Ovid Therapeutics (OVID) RSU compensation - Stock Titan

Apr 09, 2026

Apr 09, 2026

Trade Recap: Why is Ovid Therapeutics Inc stock going up2026 Top Gainers & Real-Time Chart Pattern Alerts - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Ovid Therapeutics Surge: Positive Phase 1 Data Ignites Market Confidence - timothysykes.com

Apr 09, 2026

Apr 09, 2026

Ovid Therapeutics (OVID): HC Wainwright & Co. Raises Price Targe - GuruFocus

Apr 09, 2026

Apr 09, 2026

H.C. Wainwright raises Ovid Therapeutics stock price target to $4 - Investing.com

Apr 09, 2026

Apr 09, 2026

Big Money Moves: Why is Ovid Therapeutics Inc stock going up - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Ovid Therapeutics Inc. (OVID) stock price, news, quote and history - Yahoo Finance UK

Apr 09, 2026

Apr 08, 2026

Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14 - The Manila Times

Apr 08, 2026

Apr 07, 2026

Ovid Therapeutics Shares Surge After Positive Phase 1 Results and Financing News - StocksToTrade

Apr 07, 2026

Apr 06, 2026

Earnings Report: Is Ovid Therapeutics Inc being accumulated by smart money2026 Breakouts & Breakdowns & Fast Gain Stock Tips - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Is Ovid Therapeutics (OVID) Stock Trending Up | Price at $2.31, Up 4.77%Open Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 06, 2026

Apr 05, 2026

Ovid Therapeutics Inc (OVID) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Apr 05, 2026

Apr 02, 2026

OVID.O Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Apr 01, 2026

OVID News & Events - intellectia.ai

Apr 01, 2026

Apr 01, 2026

IPO Launch: Does Ovid Therapeutics Inc have declining or rising EPSWeekly Trend Recap & Daily Growth Stock Investment Tips - baoquankhu1.vn

Apr 01, 2026

Mar 31, 2026

Gains Report: Can Ovid Therapeutics Inc maintain its current growth rate2026 Opening Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Ovid Therapeutics (OVID) price target increased by 14.29% to 4.87 - MSN

Mar 31, 2026

Mar 31, 2026

Rate Hike: Is Ovid Therapeutics Inc still a buy after recent gains2026 Chart Watch & High Accuracy Trade Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

OVID Therapeutics Inc (NASDAQ:OVID) Passes Minervini's High-Growth Momentum and Trend Template Filters - ChartMill

Mar 30, 2026

Mar 29, 2026

Aug Reactions: How does Ovid Therapeutics Inc score in quality rankingsCEO Change & Weekly Stock Performance Updates - baoquankhu1.vn

Mar 29, 2026